PDT Partners’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-424,569
Closed -$9.1M 689
2025
Q2
$9.1M Buy
424,569
+130,896
+45% +$1.95M 0.51% 32
2025
Q1
$3.85M Buy
+293,673
New +$4.36M 0.27% 112
2023
Q4
Sell
-24,192
Closed -$135K 638
2023
Q3
$135K Hold
24,192
0.02% 543
2023
Q2
$195K Sell
24,192
-3,100
-11% -$22.9K 0.03% 504
2023
Q1
$178K Sell
27,292
-27,600
-50% -$113K 0.02% 509
2022
Q4
$135K Buy
54,892
+3,610
+7% +$11.3K 0.02% 565
2022
Q3
$256K Buy
+51,282
New +$299K 0.04% 643

Other funds holding OSCR

PDT Partners's OSCR Position: Q3 2025 in Review

PDT Partners sold out of Oscar Health (OSCR) in Q3 2025, closing a stake of 424,569 shares — an estimated $9.1M sold.

PDT Partners first reported a position in OSCR in Q3 2022 and held it in 7 quarters. The position peaked at $9.1M in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q3 2025.

  • PDT Partners reported no remaining Oscar Health position as of Q3 2025 after selling out during the quarter.
  • PDT Partners sold 424,569 Oscar Health shares in Q3 2025, an estimated $9.1M.
  • PDT Partners first reported a position in Oscar Health in Q3 2022 and held it in 7 quarters.
  • PDT Partners's Oscar Health position peaked at $9.1M in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Oscar Health as of Q3 2025.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.